ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
1553267_a_at	CCR4-NOT transcription complex subunit 6 like(CNOT6L)	Homo sapiens			Function unknown,	GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0008284~positive regulation of cell proliferation,GO:0010606~positive regulation of cytoplasmic mRNA processing body assembly,GO:0031047~gene silencing by RNA,GO:0061157~mRNA destabilization,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030014~CCR4-NOT complex,	GO:0004535~poly(A)-specific ribonuclease activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR005135:Endonuclease/exonuclease/phosphatase,	hsa03018:RNA degradation,			SM00369:LRR_TYP,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Exonuclease,Hydrolase,Leucine-rich repeat,Magnesium,Metal-binding,mRNA processing,Nuclease,Nucleus,Proteomics identification,Reference proteome,Repeat,RNA-mediated gene silencing,Transcription,Transcription regulation,Translation regulation,	chain:CCR4-NOT transcription complex subunit 6- like,mutagenesis site,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,sequence conflict,splice variant,
236257_at	CD2 associated protein(CD2AP)	Homo sapiens				GO:0006461~protein complex assembly,GO:0006930~substrate-dependent cell migration, cell extension,GO:0007010~cytoskeleton organization,GO:0007067~mitotic nuclear division,GO:0007165~signal transduction,GO:0016050~vesicle organization,GO:0016337~single organismal cell-cell adhesion,GO:0032911~negative regulation of transforming growth factor beta1 production,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0048259~regulation of receptor-mediated endocytosis,GO:0051301~cell division,GO:1900182~positive regulation of protein localization to nucleus,GO:2000249~regulation of actin cytoskeleton reorganization,	GO:0001726~ruffle,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0015629~actin cytoskeleton,GO:0030139~endocytic vesicle,GO:0031941~filamentous actin,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005172~vascular endothelial growth factor receptor binding,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008022~protein C-terminus binding,GO:0017124~SH3 domain binding,GO:0032403~protein complex binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001452:Src homology-3 domain,	hsa05100:Bacterial invasion of epithelial cells,	607832~Glomerulosclerosis, focal segmental, 3,		SM00326:SH3,	3D-structure,Cell cycle,Cell division,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Mitosis,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SH3 domain,SH3-binding,Ubl conjugation,	chain:CD2-associated protein,compositionally biased region:Pro-rich,domain:SH3 1; truncated,domain:SH3 2,domain:SH3 3,helix,modified residue,region of interest:Interaction with ANLN and localization to the midbody,sequence variant,short sequence motif:SH3-binding,strand,turn,
201510_at	E74 like ETS transcription factor 3(ELF3)	Homo sapiens				GO:0001824~blastocyst development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007275~multicellular organism development,GO:0008544~epidermis development,GO:0030198~extracellular matrix organization,GO:0030855~epithelial cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060056~mammary gland involution,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,				SM00251:SAM_PNT,SM00413:ETS,	3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,DNA-binding,Inflammatory response,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:ETS-related transcription factor Elf-3,DNA-binding region:ETS,domain:PNT,helix,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
228188_at	FOS like 2, AP-1 transcription factor subunit(FOSL2)	Homo sapiens		h_ranklPathway:Bone Remodelling,		GO:0003334~keratinocyte development,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008219~cell death,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048146~positive regulation of fibroblast proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000837:Fos transforming protein,IPR004827:Basic-leucine zipper domain,	hsa04380:Osteoclast differentiation,			SM00338:BRLZ,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Fos-related antigen 2,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,
244584_at	KIAA1549 like(KIAA1549L)	Homo sapiens					GO:0016021~integral component of membrane,		IPR024606:Protein of unknown function DUF3827,					Alternative splicing,Coiled coil,Complete proteome,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:UPF0606 protein C11orf41,compositionally biased region:Poly-Ile,compositionally biased region:Poly-Pro,splice variant,transmembrane region,
222105_s_at	NFKB inhibitor interacting Ras like 2(NKIRAS2)	Homo sapiens				GO:0007165~signal transduction,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007264~small GTPase mediated signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,Cytoplasm,GTP-binding,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:NF-kappa-B inhibitor-interacting Ras-like protein 2,nucleotide phosphate-binding region:GTP,region of interest:Small GTPase-like,short sequence motif:Effector region,splice variant,
232520_s_at	NSFL1 cofactor(NSFL1C)	Homo sapiens				GO:0007030~Golgi organization,GO:0031468~nuclear envelope reassembly,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0061025~membrane fusion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005795~Golgi stack,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0045111~intermediate filament cytoskeleton,GO:1990730~VCP-NSFL1C complex,	GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0043130~ubiquitin binding,GO:0051117~ATPase binding,	IPR001012:UBX,IPR009060:UBA-like,IPR012989:SEP domain,	hsa04141:Protein processing in endoplasmic reticulum,			SM00166:UBX,SM00553:SEP,	3D-structure,Alternative splicing,Chromosome,Complete proteome,Direct protein sequencing,Golgi apparatus,Lipid-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:NSFL1 cofactor p47,compositionally biased region:Poly-Glu,domain:SEP,domain:UBX,helix,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,turn,
219661_at	RAN binding protein 17(RANBP17)	Homo sapiens			Nuclear structure / Intracellular trafficking and secretion,	GO:0006606~protein import into nucleus,GO:0006611~protein export from nucleus,GO:0006886~intracellular protein transport,GO:0051028~mRNA transport,	GO:0005622~intracellular,GO:0005643~nuclear pore,GO:0005737~cytoplasm,	GO:0005049~nuclear export signal receptor activity,GO:0005525~GTP binding,GO:0008536~Ran GTPase binding,	IPR001494:Importin-beta, N-terminal,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,				SM00913:SM00913,	Acetylation,Alternative splicing,Complete proteome,Cytoplasm,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,Translocation,Transport,	chain:Ran-binding protein 17,sequence conflict,
227983_at	Rab interacting lysosomal protein like 2(RILPL2)	Homo sapiens				GO:0003382~epithelial cell morphogenesis,GO:0060271~cilium morphogenesis,GO:1903445~protein transport from ciliary membrane to plasma membrane,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005929~cilium,GO:0016020~membrane,GO:0036064~ciliary basal body,GO:0070062~extracellular exosome,GO:0072372~primary cilium,	GO:0031267~small GTPase binding,GO:0042802~identical protein binding,GO:0051959~dynein light intermediate chain binding,	IPR021563:Rab interacting lysosomal protein,					Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Protein transport,Reference proteome,Transport,	chain:RILP-like protein 2,compositionally biased region:Poly-Glu,domain:RILP-like,
1561269_at	Rap guanine nucleotide exchange factor 5(RAPGEF5)	Homo sapiens		h_ghrelinPathway:Ghrelin: Regulation of Food Intake and Energy Homeostasis,		GO:0007264~small GTPase mediated signal transduction,GO:0007399~nervous system development,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0017034~Rap guanyl-nucleotide exchange factor activity,GO:0030742~GTP-dependent protein binding,	IPR000591:DEP domain,IPR000651:Ras-like guanine nucleotide exchange factor, N-terminal,IPR001895:Guanine-nucleotide dissociation stimulator CDC25,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR019804:Ras guanine-nucleotide exchange factor, conserved site,IPR023578:Ras guanine nucleotide exchange factor, domain,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,			SM00049:DEP,SM00147:RasGEF,SM00229:RasGEFN,	3D-structure,Alternative splicing,Complete proteome,Guanine-nucleotide releasing factor,Nucleus,Proteomics identification,Reference proteome,Signal,	chain:Rap guanine nucleotide exchange factor 5,domain:N-terminal Ras-GEF,domain:Ras-GEF,helix,sequence conflict,splice variant,strand,
238909_at	S100 calcium binding protein A10(S100A10)	Homo sapiens				GO:0001765~membrane raft assembly,GO:0006900~membrane budding,GO:0043547~positive regulation of GTPase activity,GO:0051099~positive regulation of binding,GO:0051290~protein heterotetramerization,GO:0051496~positive regulation of stress fiber assembly,GO:0051894~positive regulation of focal adhesion assembly,GO:0090002~establishment of protein localization to plasma membrane,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0016021~integral component of membrane,GO:0019897~extrinsic component of plasma membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0042803~protein homodimerization activity,GO:0044325~ion channel binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,				SM01394:SM01394,	3D-structure,Acetylation,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein S100-A10,helix,modified residue,region of interest:Ancestral calcium site,strand,
201851_at	SH3 domain containing GRB2 like 1, endophilin A2(SH3GL1)	Homo sapiens				GO:0006897~endocytosis,GO:0007165~signal transduction,GO:0007417~central nervous system development,GO:0098609~cell-cell adhesion,	GO:0002102~podosome,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0031901~early endosome membrane,GO:0042995~cell projection,	GO:0005515~protein binding,GO:0008289~lipid binding,GO:0019902~phosphatase binding,GO:0042802~identical protein binding,GO:0051020~GTPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001452:Src homology-3 domain,IPR004148:BAR domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,	hsa04144:Endocytosis,	601626~Leukemia, acute myeloid,		SM00326:SH3,SM00721:BAR,	Alternative splicing,Cell junction,Cell projection,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Endocytosis,Endosome,Lipid-binding,Membrane,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,SH3 domain,	chain:Endophilin-A2,domain:BAR,domain:SH3,modified residue,region of interest:Interaction with ARC,region of interest:Membrane-binding amphipathic helix,region of interest:Required for dimerization upon membrane association,site:Breakpoint for translocation to form MLL- EEN oncogene,
204639_at	adenosine deaminase(ADA)	Homo sapiens				GO:0001666~response to hypoxia,GO:0001821~histamine secretion,GO:0001829~trophectodermal cell differentiation,GO:0001889~liver development,GO:0001890~placenta development,GO:0002314~germinal center B cell differentiation,GO:0002636~positive regulation of germinal center formation,GO:0002686~negative regulation of leukocyte migration,GO:0002906~negative regulation of mature B cell apoptotic process,GO:0006154~adenosine catabolic process,GO:0006157~deoxyadenosine catabolic process,GO:0007568~aging,GO:0009168~purine ribonucleoside monophosphate biosynthetic process,GO:0010460~positive regulation of heart rate,GO:0030890~positive regulation of B cell proliferation,GO:0032261~purine nucleotide salvage,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0033197~response to vitamin E,GO:0033632~regulation of cell-cell adhesion mediated by integrin,GO:0042110~T cell activation,GO:0042323~negative regulation of circadian sleep/wake cycle, non-REM sleep,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043101~purine-containing compound salvage,GO:0043103~hypoxanthine salvage,GO:0043278~response to morphine,GO:0045987~positive regulation of smooth muscle contraction,GO:0046061~dATP catabolic process,GO:0046101~hypoxanthine biosynthetic process,GO:0046103~inosine biosynthetic process,GO:0046111~xanthine biosynthetic process,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0048286~lung alveolus development,GO:0048541~Peyer's patch development,GO:0048566~embryonic digestive tract development,GO:0050728~negative regulation of inflammatory response,GO:0050850~positive regulation of calcium-mediated signaling,GO:0050862~positive regulation of T cell receptor signaling pathway,GO:0060169~negative regulation of adenosine receptor signaling pathway,GO:0060407~negative regulation of penile erection,GO:0070244~negative regulation of thymocyte apoptotic process,GO:0070256~negative regulation of mucus secretion,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0030054~cell junction,GO:0032839~dendrite cytoplasm,GO:0043025~neuronal cell body,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,	GO:0001883~purine nucleoside binding,GO:0004000~adenosine deaminase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019239~deaminase activity,	IPR001365:Adenosine/AMP deaminase domain,IPR006330:Adenosine/adenine deaminase,IPR006650:Adenosine/AMP deaminase active site,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa05340:Primary immunodeficiency,	102700~Adenosine deaminase deficiency, partial,102700~Severe combined immunodeficiency due to ADA deficiency,			3D-structure,Acetylation,Cell adhesion,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Direct protein sequencing,Disease mutation,Hereditary hemolytic anemia,Hydrolase,Membrane,Metal-binding,Nucleotide metabolism,Polymorphism,Proteomics identification,Reference proteome,SCID,Zinc,	chain:Adenosine deaminase,helix,modified residue,sequence conflict,sequence variant,strand,turn,
203984_s_at	caspase 9(CASP9)	Homo sapiens	150.caspase_and_NFKB_activation,36.Death_of_Key_Intracellular_Targets,69.Survival_signaling_BH3-Bad,72.IAP_interaction_with_cell_death_pathways,86.Apoptosis_Nematode&_Vert,	h_aktPathway:AKT Signaling Pathway,h_caspasePathway:Caspase Cascade in Apoptosis,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_d4gdiPathway:D4-GDI Signaling Pathway,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_hsp27Pathway:Stress Induction of HSP Regulation,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_rasPathway:Ras Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_WNVpathway:West Nile Virus,		GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007568~aging,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008635~activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0030220~platelet formation,GO:0032025~response to cobalt ion,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0034349~glial cell apoptotic process,GO:0034644~cellular response to UV,GO:0042770~signal transduction in response to DNA damage,GO:0042981~regulation of apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0046677~response to antibiotic,GO:0071549~cellular response to dexamethasone stimulus,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:2001020~regulation of response to DNA damage stimulus,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0043293~apoptosome,	GO:0004197~cysteine-type endopeptidase activity,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0008233~peptidase activity,GO:0017124~SH3 domain binding,GO:0019901~protein kinase binding,GO:0097153~cysteine-type endopeptidase activity involved in apoptotic process,	IPR001309:Peptidase C14, ICE, catalytic subunit p20,IPR001315:Caspase Recruitment,IPR002138:Peptidase C14, caspase non-catalytic subunit p10,IPR011029:Death-like domain,IPR015917:Peptidase C14, caspase precursor p45, core,IPR016129:Peptidase C14, ICE, catalytic subunit p20, active site,IPR017350:Caspase, interleukin-1 beta convertase,	hsa04115:p53 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05016:Huntington's disease,hsa05134:Legionellosis,hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05416:Viral myocarditis,		PIRSF038001:caspase, interleukin-1 beta convertase type,	SM00114:CARD,SM00115:CASc,	3D-structure,Alternative splicing,Apoptosis,Complete proteome,Hydrolase,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Zymogen,	chain:Caspase-9 subunit p10,chain:Caspase-9 subunit p35,domain:CARD,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
235605_at	castor zinc finger 1(CASZ1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007417~central nervous system development,GO:0045664~regulation of neuron differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,Developmental protein,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein castor homolog 1,compositionally biased region:Ala-rich,compositionally biased region:Asp-rich,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,sequence conflict,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,
213981_at	catechol-O-methyltransferase(COMT)	Homo sapiens				GO:0006584~catecholamine metabolic process,GO:0007565~female pregnancy,GO:0007612~learning,GO:0007614~short-term memory,GO:0008210~estrogen metabolic process,GO:0014070~response to organic cyclic compound,GO:0016036~cellular response to phosphate starvation,GO:0032259~methylation,GO:0032496~response to lipopolysaccharide,GO:0032502~developmental process,GO:0035814~negative regulation of renal sodium excretion,GO:0042135~neurotransmitter catabolic process,GO:0042420~dopamine catabolic process,GO:0042493~response to drug,GO:0045963~negative regulation of dopamine metabolic process,GO:0048265~response to pain,GO:0048609~multicellular organismal reproductive process,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0050668~positive regulation of homocysteine metabolic process,GO:0051930~regulation of sensory perception of pain,	GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0043197~dendritic spine,GO:0044297~cell body,GO:0045211~postsynaptic membrane,GO:0070062~extracellular exosome,	GO:0000287~magnesium ion binding,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008171~O-methyltransferase activity,GO:0016206~catechol O-methyltransferase activity,	IPR002935:O-methyltransferase, family 3,IPR017128:Catechol O-methyltransferase, eukaryotic,	hsa00140:Steroid hormone biosynthesis,hsa00350:Tyrosine metabolism,hsa01100:Metabolic pathways,hsa04728:Dopaminergic synapse,	167870~Panic disorder, susceptibility to,181500~Schizophrenia, susceptibility to,	PIRSF037177:catechol O-methyltransferase, eukaryotic type,		3D-structure,Alternative initiation,Catecholamine metabolism,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Magnesium,Membrane,Metal-binding,Methyltransferase,Neurotransmitter degradation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	binding site:S-adenosyl-L-methionine,binding site:S-adenosyl-L-methionine; via amide nitrogen,binding site:Substrate,chain:Catechol O-methyltransferase,helix,metal ion-binding site:Magnesium,modified residue,region of interest:S-adenosyl-L-methionine binding,sequence conflict,sequence variant,splice variant,strand,transmembrane region,
225096_at	coordinator of PRMT5 and differentiation stimulator(COPRS)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007517~muscle organ development,GO:0043985~histone H4-R3 methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0042393~histone binding,						Acetylation,Chromatin regulator,Complete proteome,Direct protein sequencing,Myogenesis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Cooperator of PRMT5,modified residue,sequence variant,
201325_s_at	epithelial membrane protein 1(EMP1)	Homo sapiens				GO:0007275~multicellular organism development,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008544~epidermis development,GO:0016049~cell growth,GO:0032060~bleb assembly,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR003932:Epithelial membrane protein EMP-1,IPR004031:PMP-22/EMP/MP20/Claudin,IPR004032:PMP-22/EMP/MP20,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Epithelial membrane protein 1,glycosylation site:N-linked (GlcNAc...),sequence variant,transmembrane region,
204257_at	fatty acid desaturase 3(FADS3)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0006636~unsaturated fatty acid biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0016491~oxidoreductase activity,	IPR001199:Cytochrome b5-like heme/steroid binding domain,IPR005804:Fatty acid desaturase, type 1,IPR012171:Fatty acid/sphingolipid desaturase,			PIRSF015921:fatty acid desaturase/sphingolipid desaturase,	SM01117:SM01117,	Complete proteome,Electron transport,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Lipid biosynthesis,Lipid metabolism,Membrane,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Fatty acid desaturase 3,domain:Cytochrome b5 heme-binding,sequence variant,short sequence motif:Histidine box-1,short sequence motif:Histidine box-2,short sequence motif:Histidine box-3,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
225703_at	fibrosin like 1(FBRSL1)	Homo sapiens						GO:0044822~poly(A) RNA binding,	IPR023246:Autism susceptibility gene 2 protein,					Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Fibrosin-1-like protein,compositionally biased region:Pro-rich,modified residue,sequence conflict,sequence variant,
206674_at	fms related tyrosine kinase 3(FLT3)	Homo sapiens		h_erythPathway:Erythrocyte Differentiation Pathway,		GO:0001776~leukocyte homeostasis,GO:0002318~myeloid progenitor cell differentiation,GO:0002328~pro-B cell differentiation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0010243~response to organonitrogen compound,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0030097~hemopoiesis,GO:0030154~cell differentiation,GO:0030183~B cell differentiation,GO:0031100~organ regeneration,GO:0035726~common myeloid progenitor cell proliferation,GO:0038084~vascular endothelial growth factor signaling pathway,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0042981~regulation of apoptotic process,GO:0043406~positive regulation of MAP kinase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0046651~lymphocyte proliferation,GO:0046777~protein autophosphorylation,GO:0071345~cellular response to cytokine stimulus,GO:0071385~cellular response to glucocorticoid stimulus,GO:0097028~dendritic cell differentiation,	GO:0005634~nucleus,GO:0005788~endoplasmic reticulum lumen,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004896~cytokine receptor activity,GO:0005021~vascular endothelial growth factor-activated receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0032403~protein complex binding,GO:0035259~glucocorticoid receptor binding,GO:0042803~protein homodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001824:Tyrosine-protein kinase, receptor class III, conserved site,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04640:Hematopoietic cell lineage,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05221:Acute myeloid leukemia,hsa05230:Central carbon metabolism in cancer,	601626~Leukemia, acute myeloid, reduced survival in, somatic,601626~Leukemia, acute myeloid, somatic,613065~Leukemia, acute lymphoblastic, somatic,		SM00219:TyrKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Immunoglobulin domain,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:FL cytokine receptor,domain:Ig-like C2-type,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
210608_s_at	fucosyltransferase 2(FUT2)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006486~protein glycosylation,GO:0036065~fucosylation,GO:0042355~L-fucose catabolic process,	GO:0005794~Golgi apparatus,GO:0009536~plastid,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,GO:0070062~extracellular exosome,	GO:0008107~galactoside 2-alpha-L-fucosyltransferase activity,GO:0008417~fucosyltransferase activity,	IPR002516:Glycosyl transferase, family 11,	hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa00603:Glycosphingolipid biosynthesis - globo series,hsa01100:Metabolic pathways,	612542~Vitamin B12 plasma level QTL1,Bombay phenotype~Bombay phenotype,Norwalk virus infection, resistance to~Norwalk virus infection, resistance to,			Alternative initiation,Blood group antigen,Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Plastid,Polymorphism,Proteomics identification,Reference proteome,Signal,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Galactoside 2-alpha-L-fucosyltransferase 2,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
202862_at	fumarylacetoacetate hydrolase(FAH)	Homo sapiens				GO:0006527~arginine catabolic process,GO:0006559~L-phenylalanine catabolic process,GO:0006572~tyrosine catabolic process,GO:0009072~aromatic amino acid family metabolic process,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004334~fumarylacetoacetase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR005959:Fumarylacetoacetase,IPR011234:Fumarylacetoacetase, C-terminal-related,IPR015377:Fumarylacetoacetase, N-terminal,	hsa00350:Tyrosine metabolism,hsa01100:Metabolic pathways,	276700~Tyrosinemia, type I,			Acetylation,Alternative splicing,Calcium,Complete proteome,Direct protein sequencing,Disease mutation,Hydrolase,Magnesium,Metal-binding,Phenylalanine catabolism,Phosphoprotein,Proteomics identification,Reference proteome,Tyrosine catabolism,	active site:Proton acceptor,binding site:Substrate,chain:Fumarylacetoacetase,metal ion-binding site:Calcium,metal ion-binding site:Magnesium,modified residue,mutagenesis site,sequence variant,
214430_at	galactosidase alpha(GLA)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0009311~oligosaccharide metabolic process,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0046477~glycosylceramide catabolic process,GO:0046479~glycosphingolipid catabolic process,GO:0051001~negative regulation of nitric-oxide synthase activity,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005794~Golgi apparatus,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004557~alpha-galactosidase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0016936~galactoside binding,GO:0042803~protein homodimerization activity,GO:0052692~raffinose alpha-galactosidase activity,	IPR000111:Glycoside hydrolase, clan GH-D,IPR002241:Glycoside hydrolase, family 27,IPR013780:Glycosyl hydrolase, family 13, all-beta,IPR013785:Aldolase-type TIM barrel,IPR017853:Glycoside hydrolase, superfamily,	hsa00052:Galactose metabolism,hsa00561:Glycerolipid metabolism,hsa00600:Sphingolipid metabolism,hsa00603:Glycosphingolipid biosynthesis - globo series,hsa04142:Lysosome,	301500~Fabry disease,301500~Fabry disease, cardiac variant,			3D-structure,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Glycosidase,Hydrolase,Lysosome,Pharmaceutical,Proteomics identification,Reference proteome,RNA editing,Signal,	active site:Nucleophile,active site:Proton donor,chain:Alpha-galactosidase A,chain:alpha-galactosidase A subunit peptide,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Substrate binding,sequence variant,signal peptide,strand,turn,
206726_at	hematopoietic prostaglandin D synthase(HPGDS)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,		GO:0006693~prostaglandin metabolic process,GO:0007165~signal transduction,GO:0007626~locomotory behavior,GO:0019371~cyclooxygenase pathway,GO:1901687~glutathione derivative biosynthetic process,GO:2000255~negative regulation of male germ cell proliferation,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000287~magnesium ion binding,GO:0004364~glutathione transferase activity,GO:0004667~prostaglandin-D synthase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,	IPR004045:Glutathione S-transferase, N-terminal,IPR004046:Glutathione S-transferase, C-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,	hsa00590:Arachidonic acid metabolism,hsa01100:Metabolic pathways,				3D-structure,Calcium,Complete proteome,Cytoplasm,Fatty acid biosynthesis,Fatty acid metabolism,Isomerase,Lipid biosynthesis,Lipid metabolism,Magnesium,Metal-binding,Prostaglandin biosynthesis,Prostaglandin metabolism,Reference proteome,Transferase,	active site:Nucleophile,chain:Hematopoietic prostaglandin D synthase,chain:Prostaglandin-H2 D-isomerase,disulfide bond,domain:GST C-terminal,domain:GST N-terminal,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,strand,turn,
206287_s_at	inter-alpha-trypsin inhibitor heavy chain family member 4(ITIH4)	Homo sapiens				GO:0002576~platelet degranulation,GO:0006953~acute-phase response,GO:0010951~negative regulation of endopeptidase activity,GO:0030212~hyaluronan metabolic process,GO:0034097~response to cytokine,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0031089~platelet dense granule lumen,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004866~endopeptidase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005515~protein binding,	IPR002035:von Willebrand factor, type A,IPR010600:Inter-alpha-trypsin inhibitor heavy chain, C-terminal,IPR013694:VIT domain,		143890~Hypercholesterolemia, susceptibility to,		SM00327:VWA,SM00609:VIT,	Acute phase,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Secreted,Serine protease inhibitor,Signal,	chain:35 kDa inter-alpha-trypsin inhibitor heavy chain H4,chain:70 kDa inter-alpha-trypsin inhibitor heavy chain H4,disulfide bond,domain:VIT,domain:VWFA,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),propeptide:Potentially active peptide,sequence conflict,sequence variant,signal peptide,splice variant,
212086_x_at	lamin A/C(LMNA)	Homo sapiens		h_caspasePathway:Caspase Cascade in Apoptosis,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0007077~mitotic nuclear envelope disassembly,GO:0007084~mitotic nuclear envelope reassembly,GO:0007517~muscle organ development,GO:0030334~regulation of cell migration,GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity,GO:0034504~protein localization to nucleus,GO:0035105~sterol regulatory element binding protein import into nucleus,GO:0036498~IRE1-mediated unfolded protein response,GO:0055015~ventricular cardiac muscle cell development,GO:0071456~cellular response to hypoxia,GO:0072201~negative regulation of mesenchymal cell proliferation,GO:0090201~negative regulation of release of cytochrome c from mitochondria,GO:0090343~positive regulation of cell aging,GO:1900180~regulation of protein localization to nucleus,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005638~lamin filament,GO:0005652~nuclear lamina,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005882~intermediate filament,GO:0016607~nuclear speck,GO:0031012~extracellular matrix,GO:0031965~nuclear membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005198~structural molecule activity,GO:0005515~protein binding,	IPR001322:Lamin Tail Domain,IPR001664:Intermediate filament protein,IPR018039:Intermediate filament protein, conserved site,	hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	115200~Cardiomyopathy, dilated, 1A,151660~Lipodystrophy, familial partial, 2,159001~Muscular dystrophy, limb-girdle, type 1B,176670~Hutchinson-Gilford progeria,181350~Emery-Dreifuss muscular dystrophy 2, AD,212112~Malouf syndrome,248370~Mandibuloacral dysplasia,275210~Restrictive dermopathy, lethal,605588~Charcot-Marie-Tooth disease, type 2B1,610140~Heart-hand syndrome, Slovenian type,613205~Muscular dystrophy, congenital,616516~Emery-Dreifuss muscular dystrophy 3, AR,		SM01391:SM01391,	3D-structure,Acetylation,Alternative splicing,Cardiomyopathy,Charcot-Marie-Tooth disease,Coiled coil,Complete proteome,Congenital muscular dystrophy,Direct protein sequencing,Disease mutation,Emery-Dreifuss muscular dystrophy,Intermediate filament,Isopeptide bond,Limb-girdle muscular dystrophy,Lipoprotein,Methylation,Neurodegeneration,Neuropathy,Nucleus,Phosphoprotein,Polymorphism,Prenylation,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Lamin-A/C,helix,lipid moiety-binding region:S-farnesyl cysteine,modified residue,mutagenesis site,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Linker 1,region of interest:Linker 2,region of interest:Rod,region of interest:Tail,sequence variant,short sequence motif:Nuclear localization signal,site:Heptad change of phase,site:Stutter,splice variant,strand,turn,
204298_s_at, 215446_s_at	lysyl oxidase(LOX)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0007507~heart development,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030324~lung development,GO:0035904~aorta development,GO:0042060~wound healing,GO:0042493~response to drug,GO:0048251~elastic fiber assembly,GO:0048545~response to steroid hormone,GO:0055114~oxidation-reduction process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0005634~nucleus,	GO:0004720~protein-lysine 6-oxidase activity,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0016641~oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,	IPR001695:Lysyl oxidase,IPR019828:Lysyl oxidase, conserved site,					Complete proteome,Copper,Disulfide bond,Glycoprotein,LTQ,Metal-binding,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,TPQ,	chain:Protein-lysine 6-oxidase,cross-link:Lysine tyrosylquinone (Lys-Tyr),glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Copper,modified residue,region of interest:Lysyl-oxidase like,sequence conflict,sequence variant,signal peptide,
229682_at	microtubule associated protein RP/EB family member 3(MAPRE3)	Homo sapiens				GO:0007067~mitotic nuclear division,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051301~cell division,GO:1903033~positive regulation of microtubule plus-end binding,	GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,GO:0030496~midbody,GO:0035371~microtubule plus-end,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0042802~identical protein binding,	IPR001715:Calponin homology domain,IPR004953:EB1, C-terminal,IPR027328:Microtubule-associated protein RP/EB,					3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Mitosis,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Microtubule-associated protein RP/EB family member 3,domain:CH,domain:EB1 C-terminal,helix,modified residue,region of interest:APC-binding,region of interest:DCTN1-binding,sequence conflict,splice variant,turn,
225673_at	myeloid associated differentiation marker(MYADM)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0010629~negative regulation of gene expression,GO:0010810~regulation of cell-substrate adhesion,GO:0030335~positive regulation of cell migration,GO:0030837~negative regulation of actin filament polymerization,GO:0031579~membrane raft organization,GO:0034115~negative regulation of heterotypic cell-cell adhesion,GO:0045217~cell-cell junction maintenance,GO:0061028~establishment of endothelial barrier,GO:0072661~protein targeting to plasma membrane,GO:0090038~negative regulation of protein kinase C signaling,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0001726~ruffle,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016021~integral component of membrane,GO:0030864~cortical actin cytoskeleton,GO:0045121~membrane raft,GO:0070062~extracellular exosome,		IPR008253:Marvel,					Complete proteome,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Myeloid-associated differentiation marker,domain:MARVEL 1,domain:MARVEL 2,modified residue,sequence conflict,transmembrane region,
205204_at	neuromedin B(NMB)	Homo sapiens				GO:0007165~signal transduction,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007218~neuropeptide signaling pathway,GO:0007267~cell-cell signaling,GO:0008284~positive regulation of cell proliferation,GO:0042593~glucose homeostasis,GO:0046887~positive regulation of hormone secretion,GO:0046888~negative regulation of hormone secretion,GO:0050482~arachidonic acid secretion,	GO:0005576~extracellular region,GO:0043005~neuron projection,	GO:0005179~hormone activity,GO:0005515~protein binding,GO:0031710~neuromedin B receptor binding,	IPR000874:Bombesin/neuromedin-B/ranatensin peptide family,					3D-structure,Alternative splicing,Amidation,Cleavage on pair of basic residues,Complete proteome,Polymorphism,Reference proteome,Secreted,Signal,	helix,modified residue,peptide:Neuromedin-B,peptide:Neuromedin-B-32,sequence conflict,sequence variant,signal peptide,splice variant,
231656_x_at	oxysterol binding protein like 10(OSBPL10)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0006869~lipid transport,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0001786~phosphatidylserine binding,GO:0015485~cholesterol binding,	IPR000648:Oxysterol-binding protein,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR018494:Oxysterol-binding protein, conserved site,				SM00233:PH,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Lipid biosynthesis,Lipid metabolism,Lipid transport,Lipid-binding,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:Oxysterol-binding protein-related protein 10,domain:PH,modified residue,sequence variant,
215671_at, 203708_at	phosphodiesterase 4B(PDE4B)	Homo sapiens				GO:0001780~neutrophil homeostasis,GO:0006198~cAMP catabolic process,GO:0007165~signal transduction,GO:0030593~neutrophil chemotaxis,GO:0032729~positive regulation of interferon-gamma production,GO:0032743~positive regulation of interleukin-2 production,GO:0035690~cellular response to drug,GO:0050852~T cell receptor signaling pathway,GO:0050900~leukocyte migration,GO:0071222~cellular response to lipopolysaccharide,GO:0071872~cellular response to epinephrine stimulus,GO:0086004~regulation of cardiac muscle cell contraction,GO:1901841~regulation of high voltage-gated calcium channel activity,GO:1901898~negative regulation of relaxation of cardiac muscle,	GO:0000930~gamma-tubulin complex,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005891~voltage-gated calcium channel complex,GO:0008021~synaptic vesicle,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030018~Z disc,GO:0043197~dendritic spine,GO:0071944~cell periphery,	GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0030552~cAMP binding,GO:0044325~ion channel binding,GO:0046872~metal ion binding,	IPR002073:3'5'-cyclic nucleotide phosphodiesterase, catalytic domain,IPR003607:HD/PDEase domain,IPR023088:3'5'-cyclic nucleotide phosphodiesterase,IPR023174:3'5'-cyclic nucleotide phosphodiesterase, conserved site,	hsa00230:Purine metabolism,hsa04024:cAMP signaling pathway,hsa05032:Morphine addiction,			SM00471:HDc,	3D-structure,Alternative splicing,cAMP,Complete proteome,Hydrolase,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Proton donor,binding site:cAMP,chain:cAMP-specific 3',5'-cyclic phosphodiesterase 4B,helix,metal ion-binding site:Divalent metal cation 1,metal ion-binding site:Divalent metal cation 2,modified residue,nucleotide phosphate-binding region:cAMP,sequence variant,site:Binds AMP, but not cAMP,splice variant,strand,turn,
209875_s_at	secreted phosphoprotein 1(SPP1)	Homo sapiens		h_npp1Pathway:Regulators of Bone Mineralization,		GO:0001503~ossification,GO:0001649~osteoblast differentiation,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007566~embryo implantation,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0031214~biomineral tissue development,GO:0033280~response to vitamin D,GO:0045780~positive regulation of bone resorption,GO:0046697~decidualization,GO:0048545~response to steroid hormone,GO:0048685~negative regulation of collateral sprouting of intact axon in response to injury,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031988~membrane-bounded vesicle,GO:0042995~cell projection,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0050840~extracellular matrix binding,	IPR002038:Osteopontin,IPR019841:Osteopontin, conserved site,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04620:Toll-like receptor signaling pathway,			SM00017:OSTEO,	3D-structure,Alternative splicing,Biomineralization,Cell adhesion,Complete proteome,Cytokine,Direct protein sequencing,Glycoprotein,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Sialic acid,Signal,	chain:Osteopontin,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,
229269_x_at	single stranded DNA binding protein 4(SSBP4)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0016021~integral component of membrane,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,	IPR006594:LisH dimerisation motif,IPR008116:Sequence-specific single-strand DNA-binding protein,				SM00667:LisH,	Acetylation,Alternative splicing,Complete proteome,DNA-binding,Membrane,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Single-stranded DNA-binding protein 4,compositionally biased region:Pro-rich,domain:LisH,modified residue,
1552803_a_at	stathmin 1(STMN1)	Homo sapiens		h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,		GO:0000281~mitotic cytokinesis,GO:0007019~microtubule depolymerization,GO:0007052~mitotic spindle organization,GO:0007165~signal transduction,GO:0007409~axonogenesis,GO:0007420~brain development,GO:0009615~response to virus,GO:0031110~regulation of microtubule polymerization or depolymerization,GO:0031115~negative regulation of microtubule polymerization,GO:0031175~neuron projection development,GO:0035556~intracellular signal transduction,GO:0051272~positive regulation of cellular component movement,GO:0051493~regulation of cytoskeleton organization,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005874~microtubule,GO:0016020~membrane,GO:0043005~neuron projection,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0015631~tubulin binding,	IPR000956:Stathmin family,	hsa04010:MAPK signaling pathway,hsa05206:MicroRNAs in cancer,		PIRSF002285:Op18/stathmin,		Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Direct protein sequencing,Methylation,Microtubule,Neurogenesis,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Stathmin,chain:Transmembrane protein C1orf215,modified residue,sequence conflict,sequence variant,transmembrane region,
218132_s_at	tRNA splicing endonuclease subunit 34(TSEN34)	Homo sapiens				GO:0000379~tRNA-type intron splice site recognition and cleavage,GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation,GO:0006397~mRNA processing,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,	GO:0000214~tRNA-intron endonuclease complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0000213~tRNA-intron endonuclease activity,GO:0003676~nucleic acid binding,GO:0016829~lyase activity,	IPR006676:tRNA-splicing endonuclease,IPR006677:tRNA intron endonuclease, catalytic domain-like,IPR011856:tRNA endonuclease-like domain,IPR016690:tRNA-splicing endonuclease, SEN34 subunit,		612390~Pontocerebellar hypoplasia type 2C,	PIRSF017250:tRNA-splicing endonuclease, SEN34 subunit,		Complete proteome,Disease mutation,Endonuclease,Hydrolase,Lyase,mRNA processing,Neurodegeneration,Nuclease,Nucleus,Polymorphism,Pontocerebellar hypoplasia,Proteomics identification,Reference proteome,tRNA processing,	chain:tRNA-splicing endonuclease subunit Sen34,modified residue,sequence variant,
210323_at	tektin 2(TEKT2)	Homo sapiens				GO:0030317~sperm motility,GO:0036159~inner dynein arm assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0031514~motile cilium,		IPR000435:Tektin,					Cell projection,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Flagellum,Microtubule,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Tektin-2,sequence conflict,sequence variant,
227972_at	torsin family 2 member A(TOR2A)	Homo sapiens				GO:0051085~chaperone mediated protein folding requiring cofactor,GO:0051260~protein homooligomerization,	GO:0005576~extracellular region,GO:0005788~endoplasmic reticulum lumen,	GO:0005524~ATP binding,	IPR001270:Chaperonin ClpA/B,IPR003593:AAA+ ATPase domain,IPR010448:Torsin,IPR017378:Torsin, subgroup,IPR027417:P-loop containing nucleoside triphosphate hydrolase,			PIRSF038079:torsin,	SM00382:AAA,	Alternative splicing,Amidation,ATP-binding,Cleavage on pair of basic residues,Complete proteome,Endoplasmic reticulum,Glycoprotein,Hormone,Nucleotide-binding,Polymorphism,Reference proteome,Secreted,Signal,	chain:Prosalusin,chain:Torsin-2A,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,peptide:Salusin-alpha,peptide:Salusin-beta,sequence variant,signal peptide,splice variant,
225912_at	tumor protein p53 inducible nuclear protein 1(TP53INP1)	Homo sapiens				GO:0000045~autophagosome assembly,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0006950~response to stress,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0009408~response to heat,GO:0010506~regulation of autophagy,GO:0010508~positive regulation of autophagy,GO:0010629~negative regulation of gene expression,GO:0030336~negative regulation of cell migration,GO:0034644~cellular response to UV,GO:0042981~regulation of apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048102~autophagic cell death,GO:0048147~negative regulation of fibroblast proliferation,GO:0071361~cellular response to ethanol,GO:0071447~cellular response to hydroperoxide,GO:0072703~cellular response to methyl methanesulfonate,GO:0098869~cellular oxidant detoxification,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1904761~negative regulation of myofibroblast differentiation,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0016605~PML body,GO:0031410~cytoplasmic vesicle,	GO:0005515~protein binding,GO:0016209~antioxidant activity,		hsa05166:HTLV-I infection,				Activator,Alternative splicing,Antioxidant,Apoptosis,Autophagy,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,Tumor suppressor,	chain:Tumor protein p53-inducible nuclear protein 1,compositionally biased region:Glu-rich,compositionally biased region:Poly-Ser,sequence variant,splice variant,
223920_s_at	tumor protein p53 regulated apoptosis inducing protein 1(TP53AIP1)	Homo sapiens				GO:0006915~apoptotic process,GO:0042981~regulation of apoptotic process,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,			hsa04115:p53 signaling pathway,				Alternative splicing,Apoptosis,Complete proteome,Mitochondrion,Polymorphism,Reference proteome,	chain:p53-regulated apoptosis-inducing protein 1,sequence variant,splice variant,
209950_s_at	villin like(VILL)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0051693~actin filament capping,	GO:0015629~actin cytoskeleton,	GO:0003779~actin binding,GO:0005200~structural constituent of cytoskeleton,	IPR003128:Villin headpiece,IPR007122:Villin/Gelsolin,IPR007123:Gelsolin domain,IPR015626:Villin-like protein,				SM00153:VHP,SM00262:GEL,	Actin capping,Actin-binding,Alternative splicing,Calcium,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Villin-like protein,domain:HP,repeat:Gelsolin-like 1,repeat:Gelsolin-like 2,repeat:Gelsolin-like 3,repeat:Gelsolin-like 4,repeat:Gelsolin-like 5,repeat:Gelsolin-like 6,sequence conflict,sequence variant,splice variant,
1560201_at	zinc finger protein 713(ZNF713)	Homo sapiens			General function prediction only,Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Autism spectrum disorder,Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Triplet repeat expansion,Zinc,Zinc-finger,	chain:Zinc finger protein 713,compositionally biased region:Poly-Glu,domain:KRAB,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
224263_x_at	zonadhesin (gene/pseudogene)(ZAN)	Homo sapiens				GO:0007339~binding of sperm to zona pellucida,GO:0016337~single organismal cell-cell adhesion,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR000742:Epidermal growth factor-like domain,IPR000998:MAM domain,IPR001007:von Willebrand factor, type C,IPR001846:von Willebrand factor, type D domain,IPR002919:Trypsin Inhibitor-like, cysteine rich domain,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR014853:Uncharacterised domain, cysteine-rich,IPR025615:TILa domain,				SM00137:MAM,SM00181:EGF,SM00214:VWC,SM00215:VWC_out,SM00216:VWD,SM00832:SM00832,	Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Zonadhesin,disulfide bond,domain:EGF-like,domain:MAM 1,domain:MAM 2,domain:MAM 3,domain:TIL 1,domain:TIL 2,domain:TIL 3,domain:TIL 4,domain:VWFC 1,domain:VWFC 2,domain:VWFC 3,domain:VWFC 4,domain:VWFC 5,domain:VWFD 1,domain:VWFD 2,domain:VWFD 3,domain:VWFD 4,glycosylation site:N-linked (GlcNAc...),region of interest:66 X heptapeptide repeats (approximate) (mucin-like domain),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
